New Express (EXPR) Tactics Lead to Big Growth

Express (EXPR), specialty retailer of clothing for consumers ages 20-30, thinks it has elevated its image among millennials using some of the same marketing tactics as Nike (NKE) and Under Armour (UA), Investor’s Business Daily reported.

Express  has signed sports stars and models to serve as “brand ambassadors.” All-Star third baseman Kris Bryant of the Chicago Cubs signed on in March with Express. He joins supermodel Kate Upton and Golden State Warriors basketball guard Steph Curry.

Since taking the helm in January 2015, Chief Executive David Kornberg has implemented a number of initiatives that have vaulted the company’s financial performance after some years of tough times. His new initiatives include the launch of new planning systems expected to come online soon, an upgrade to Express’ e-commerce experience and a continued rollout of its off-price store concept.

Kornberg’s efforts are bearing fruit. Express has logged four straight quarters of at least double-digit earnings growth. After a strong performance in 2015, Express is expected to keep up its winning streak.

EXPR is a Cabot Top Ten Trader stock.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >